Company intelligence / Profile preview

Emobot

Paris, Île-de-France, Franceemobot.fr ↗

Ownership: Private
Development stage: Preclinical

Overview

Emobot has developed a clinically validated AI-powered device and app that continuously monitors emotional states to detect and track mood disorders. Its technology is being used in clinical trials, nursing homes, hospitals, and is expanding into the US market. The EmoSense platform provides real-time data for both clinical care and as a digital endpoint in psychiatric drug development. The company’s second-generation product, EmoDTx, delivers personalized digital therapeutics based on CBT principles for patients with mood disorders or chronic illnesses.

Therapeutic areas: Psychiatry
Modalities: DeviceDigital TherapeuticsNon-pharmacological therapy (CBT-based)
Industry: Digital Health Medical Devices

Drug pipeline

2 assets

EmoDTx

Pre-clinical

Indications: Major Depressive Disorder, Mood disorders

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborations with ~30 hospitals across Europe for clinical trialsPartnerships/pilots with nursing home groups such as Bridge Group France

Beyond the preview

Go deeper on Emobot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emobot.

Explore the full profile